Temat: "Clinical Trials as Topic" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Similarities and Differences Between Pragmatic Trials and Hybrid Effectiveness-Implementation Trials.
Autorzy:: Fortney JC; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, USA. .; Department of Veterans Affairs, Health Systems Research, Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, WA, USA. .
Curran GM; College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Department of Nursing and Midwifery, University of Limerick, Limerick, Ireland.
Lyon AR; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Check DK; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA.
Flum DR; Department of Surgery, School of Medicine, University of Washington, Seattle, WA, USA.; Pokaż więcej
Źródło:: Journal of general internal medicine [J Gen Intern Med] 2024 Jul; Vol. 39 (9), pp. 1735-1743. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Pragmatic Clinical Trials as Topic*/methods
Humans ; Clinical Trials as Topic/methods ; Clinical Trials as Topic/standards ; Evidence-Based Medicine/methods ; Evidence-Based Medicine/standards ; Research Design

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Dissemination and outcome reporting bias in clinical malaria intervention trials: a cross-sectional analysis.
Autorzy:: Pool L; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Ruiz Del Portal Luyten C; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
van der Pluijm RW; Université Paris Cité, G5 Infectious Disease Epidemiology and Analytics, Institut Pasteur, 75015, Paris, France.
Soentjens P; Department of Clinical Sciences, Institute of Tropical Medicine (ITM), Antwerp, Belgium.
Hanscheid T; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Grobusch MP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.; Masanga Medical Research Unit (MMRU), Masanga, Sierra Leone.; Centre de Recherches Médicales en Lambaréné (CERMEL), Lambaréné, Gabon.; Institute of Tropical Medicine & Deutsches Zentrum Für Infektionsforschung, University of Tübingen, Tübingen, Germany.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Visser BJ; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. .; Department of Clinical Sciences, Institute of Tropical Medicine (ITM), Antwerp, Belgium. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Sep 30; Vol. 23 (1), pp. 293. Date of Electronic Publication: 2024 Sep 30.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria*/prevention & control
Clinical Trials as Topic*/statistics & numerical data
Clinical Trials as Topic*/standards
Cross-Sectional Studies ; Humans ; Publication Bias/statistics & numerical data ; Information Dissemination

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Sample size recalculation in three-stage clinical trials and its evaluation.
Autorzy:: Bokelmann B; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, 10117, Germany. .
Rauch G; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, 10117, Germany.; Technische Universität Berlin, Straße des 17. Juni 135, Berlin, 10623, Germany.
Meis J; Institute of Medical Biometry, University Medical Center Ruprechts-Karls University Heidelberg, Im Neuenheimer Feld 130.3, Heidelberg, 69120, Germany.
Kieser M; Institute of Medical Biometry, University Medical Center Ruprechts-Karls University Heidelberg, Im Neuenheimer Feld 130.3, Heidelberg, 69120, Germany.
Herrmann C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, 10117, Germany.; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2024 Sep 25; Vol. 24 (1), pp. 214. Date of Electronic Publication: 2024 Sep 25.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Trials as Topic*/methods
Clinical Trials as Topic*/statistics & numerical data
Research Design*/statistics & numerical data
Sample Size ; Humans ; Computer Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Challenges and opportunities of translating animal research into human trials in Ethiopia.
Autorzy:: Abrhaley A; Department of Biomedical Sciences, College of Veterinary Medicine and Animal Sciences, University of Gondar, P.O. Box: 196, Gondar, Ethiopia. .; Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia. .
Giday M; Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia.; Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Hailu A; Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia.; Department of Microbiology, Immunology, and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2024 Sep 19; Vol. 24 (1), pp. 211. Date of Electronic Publication: 2024 Sep 19.
Typ publikacji:: Journal Article
MeSH Terms:: Translational Research, Biomedical*/methods
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/statistics & numerical data
Animal Experimentation*/statistics & numerical data
Ethiopia ; Humans ; Animals ; Qualitative Research ; Reproducibility of Results ; Research Personnel/statistics & numerical data

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Identifying trials run in India that are registered in other clinical trial registries: a cross-sectional study.
Autorzy:: Borah R; Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India.
Samanta AD; Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India.
Mendiratta J; Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India.
Mishra M; Aganitha Cognitive Solutions, Hyderabad, Telangana, India.
Saberwal G; Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2024 Sep 12; Vol. 24 (1), pp. 201. Date of Electronic Publication: 2024 Sep 12.
Typ publikacji:: Journal Article
MeSH Terms:: Registries*/statistics & numerical data
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/statistics & numerical data
Clinical Trials as Topic*/standards
India ; Humans ; Cross-Sectional Studies ; Biomedical Research/statistics & numerical data ; Biomedical Research/methods ; Biomedical Research/standards ; Data Accuracy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinical Trials in Portugal: Past and Future. Position Paper from the Colleges of Clinical Pharmacology and Pharmaceutical Medicine.
Autorzy:: Borges-Carneiro F; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Torre Souto M; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Silva I; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Leão Moreira P; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Ferraz de Oliveira P; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Lopes DJ; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal.
Figueira L; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal; Center for Drug Discovery and Innovative Medicines (MedInUP). Faculty of Medicine. Universidade do Porto. Porto. Portugal; Department of Ophthalmology. Unidade Local de Saúde São João. Porto. Portugal.
Reina-Couto M; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal; Intensive Care Medicine Department. Unidade Local de Saúde São João. Porto. Portugal.; College of Clinical Pharmacology. Ordem dos Médicos. Lisbon. Portugal.
Cunha-Miranda L; Portuguese Institute of Rheumatology. Lisbon. Portugal.; College of Pharmaceutical Medicine. Ordem dos Médicos. Lisbon. Portugal.
Ponces Bento D; College of Pharmaceutical Medicine. Ordem dos Médicos. Lisbon. Portugal.; Department of Infectious Diseases. Unidade Local de Saúde de São José. Lisbon. Portugal.
Magro F; Clinical Pharmacology Unit. Unidade Local de Saúde São João. Porto. Portugal; . Faculty of Medicine. Universidade do Porto. Porto, Portugal.; Pokaż więcej
Źródło:: Acta medica portuguesa [Acta Med Port] 2024 Sep 02; Vol. 37 (9), pp. 585-588. Date of Electronic Publication: 2024 Jul 31.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Trials as Topic*/standards
Portugal ; Humans ; Pharmacology, Clinical ; Forecasting

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.
Autorzy:: Zarbock A; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of Münster, Albert-Schweitzer Campus 1, Building A1, 48149, Münster, Germany. .; Outcomes Research Consortium, Cleveland, OH, USA. .
Forni LG; Depatment of Critical Care, Royal Surrey Hospital Foundation Trust, Guildford, Surrey, UK.; School of Medicine, Kate Granger Building, University of Surrey, Guildford, Surrey, UK.
Koyner JL; Section of Nephrology, University of Chicago, Chicago, IL, USA.
Bell S; Division of Population Health and Genomics, University of Dundee, Dundee, UK.
Reis T; Hospital Sírio-Libanês, São Paulo, Brazil.; Fenix Nephrology, São Paulo, Brazil.; Laboratory of Molecular Pharmacology, University of Brasília, Brasília, Brazil.
Meersch M; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of Münster, Albert-Schweitzer Campus 1, Building A1, 48149, Münster, Germany.
Bagshaw SM; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.
Fuhmann DY; UPMC Children's Hospital of Pittsburgh, 4401 Penn Avenue, Suite 2000, Pittsburgh, PA, 15224, USA.; Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Liu KD; Departments of Medicine and Anesthesia, University of California, San Francisco, San Francisco, CA, USA.
Pannu N; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Arikan AA; Division of Nephrology and Critical Care Medicine, Department of Pediatric, Baylor College of Medicine, Houston, TX, USA.
Angus DC; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Duquette D; Critical Care Strategic Clinical Network, Alberta Health Services, Calgary, Canada.
Goldstein SL; Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
Hoste E; Intensive Care Unit, Ghent University Hospital, Ghent University, Ghent, Belgium.
Joannidis M; Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Legrand M; Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, UCSF, San Francisco, CA, USA.
Mehta RL; Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA.
Murray PT; School of Medicine, University College Dublin, Dublin, Ireland.
Nadim MK; Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Ostermann M; Department of Intensive Care, King's College London, Thomas' Hospital, Guy's & St, London, UK.
Prowle J; Faculty of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK.
See EJ; Department of Critical Care, University of Melbourne, Parkville, Australia.; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Nephrology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Selby NM; Centre for Kidney Research and Innovation, University of Nottingham, Nottingham, UK.
Shaw AD; Department of Intensive Care and Resuscitation, The Cleveland Clinic, Cleveland, OH, USA.
Srisawat N; Division of Nephrology, Department of Medicine, Faculty of Medicine, and Center of Excellence in Critical Care Nephrology, Chulalongkorn University, Bangkok, Thailand.
Ronco C; Department of Medicine, University of Padova, Padua, Italy.; International Renal Research Institute of Vicenza (IRRV), Vicenza, Italy.; Department of Nephrology, San Bortolo Hospital, Vicenza, Italy.
Kellum JA; Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Pokaż więcej
Źródło:: Intensive care medicine [Intensive Care Med] 2024 Sep; Vol. 50 (9), pp. 1426-1437. Date of Electronic Publication: 2024 Aug 08.
Typ publikacji:: Journal Article; Consensus Development Conference
MeSH Terms:: Acute Kidney Injury*/therapy
Acute Kidney Injury*/prevention & control
Research Design*/standards
Clinical Trials as Topic*/standards
Clinical Trials as Topic*/methods
Humans ; Consensus ; Delphi Technique

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: Assessing the Role of Patient Generation Techniques in Virtual Clinical Trial Outcomes.
Autorzy:: Gevertz JL; Department of Mathematics and Statistics, The College of New Jersey, 2000 Pennington Rd, Ewing, NJ, 08628, USA. .
Wares JR; Department of Mathematics and Statistics, University of Richmond, 410 Westhampton Way, Richmond, VA, 23173, USA.; Pokaż więcej
Źródło:: Bulletin of mathematical biology [Bull Math Biol] 2024 Aug 13; Vol. 86 (10), pp. 119. Date of Electronic Publication: 2024 Aug 13.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Trials as Topic*/statistics & numerical data
Clinical Trials as Topic*/methods
Computer Simulation*
Mathematical Concepts*
Humans ; Treatment Outcome ; Patient Selection ; Bayes Theorem

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Silence is golden, but my measures still see-why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards.
Autorzy:: Woolf B; Department of Psychological Science, University of Bristol, 12a Priory Road, Bristol, BS8 1TU, UK. .; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK. .; Faculty of Epidemiology and Population Health, London, School of Hygiene and Tropical Medicine , London, UK. .; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK. .
Pedder H; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Rodriguez-Broadbent H; Department of Mathematics, Imperial College London, London, UK.
Edwards P; Faculty of Epidemiology and Population Health, London, School of Hygiene and Tropical Medicine , London, UK.; Pokaż więcej
Źródło:: Trials [Trials] 2024 Aug 12; Vol. 25 (1), pp. 532. Date of Electronic Publication: 2024 Aug 12.
Typ publikacji:: Journal Article
MeSH Terms:: Cost-Benefit Analysis*
Research Design*/standards
Clinical Trials as Topic*/economics
Clinical Trials as Topic*/standards
Humans ; Surveys and Questionnaires ; Reproducibility of Results ; Sample Size ; Treatment Outcome ; Models, Economic ; Endpoint Determination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Quantitative Gait and Balance Outcomes for Ataxia Trials: Consensus Recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers.
Autorzy:: Ilg W; Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, Otfried-Müller-Straße 25, 72076, Tübingen, Germany. .; Centre for Integrative Neuroscience (CIN), Tübingen, Germany. .
Milne S; Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Paediatrics, Melbourne University, Melbourne, VIC, Australia.; Physiotherapy Department, Monash Health, Clayton, VIC, Australia.; School of Primary and Allied Health Care, Monash University, Frankston, VIC, Australia.
Schmitz-Hübsch T; Experimental and Clinical Research Center, a cooperation of Max-Delbrueck Center for Molecular Medicine and Charité, Universitätsmedizin Berlin, Berlin, Germany.; Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alcock L; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK.
Beichert L; Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Bertini E; Research Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital, IRCCS, Rome, Italy.
Mohamed Ibrahim N; Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Dawes H; NIHR Exeter BRC, College of Medicine and Health, University of Exeter, Exeter, UK.
Gomez CM; Department of Neurology, The University of Chicago, Chicago, USA.
Hanagasi H; Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Kinnunen KM; IXICO, London, UK.
Minnerop M; Institute of Neuroscience and Medicine (INM-1)), Research Centre Juelich, Juelich, Germany.; Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty & University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty & University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Németh AH; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Newman J; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK.; Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Ng YS; Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Rentz C; Institute of Neuroscience and Medicine (INM-1)), Research Centre Juelich, Juelich, Germany.
Samanci B; Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Shah VV; Department of Neurology, Oregon Health & Science University, Portland, OR, USA.; APDM Precision Motion, Clario, Portland, OR, USA.
Summa S; Movement Analysis and Robotics Laboratory (MARLab), Neurorehabilitation Unit, Neurological Science and Neurorehabilitation Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Vasco G; Movement Analysis and Robotics Laboratory (MARLab), Neurorehabilitation Unit, Neurological Science and Neurorehabilitation Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
McNames J; APDM Precision Motion, Clario, Portland, OR, USA.; Department of Electrical and Computer Engineering, Portland State University, Portland, OR, USA.
Horak FB; Department of Neurology, Oregon Health & Science University, Portland, OR, USA.; APDM Precision Motion, Clario, Portland, OR, USA.; Pokaż więcej
Corporate Authors:: Ataxia Global Initiative (AGI) working group Digital Motor Biomarkers
Źródło:: Cerebellum (London, England) [Cerebellum] 2024 Aug; Vol. 23 (4), pp. 1566-1592. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Consensus*
Postural Balance*/physiology
Gait*/physiology
Biomarkers*
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/standards
Humans ; Ataxia/diagnosis ; Gait Disorders, Neurologic/therapy ; Gait Disorders, Neurologic/diagnosis ; Gait Disorders, Neurologic/physiopathology ; Gait Analysis/methods ; Cerebellar Ataxia/drug therapy ; Cerebellar Ataxia/diagnosis ; Cerebellar Ataxia/therapy ; Cerebellar Ataxia/physiopathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Selecting trial centers using a standardized, automated site assessment survey instrument (SASI).
Autorzy:: Lane K; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Hillery S; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Majkowski R; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Barney BJ; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: .
Amirault D; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Nelson SJ; Vanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA. Electronic address: .
Bailey M; Duke Clinical Research Institute, Durham, NC, USA. Electronic address: .
Unsicker EH; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: .
Stroud M; Vanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA. Electronic address: .
Eyzaguirre LM; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Gawad A; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Nanni A; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Mirzoyan G; Wake Forest University School of Medicine, Winston-Salem, NC, USA. Electronic address: .
Cohen T; Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Waddy SP; National Center for Advancing Translational Sciences, Bethesda, MD, USA. Electronic address: .
Wiley K; National Center for Advancing Translational Sciences, Bethesda, MD, USA. Electronic address: .
Harris PA; Vanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: .
Ford DE; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Institute for Clinical and Translational Research, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .
Hanley D; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: .; Pokaż więcej
Corporate Authors:: Trial Innovation Network
Źródło:: Contemporary clinical trials [Contemp Clin Trials] 2024 Aug; Vol. 143, pp. 107583. Date of Electronic Publication: 2024 May 29.
Typ publikacji:: Journal Article
MeSH Terms:: Clinical Trials as Topic*/standards
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/organization & administration
Humans ; Surveys and Questionnaires/standards ; Multicenter Studies as Topic/methods ; Multicenter Studies as Topic/standards

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials.
Autorzy:: Zitzmann S; Medical School Hamburg, Hamburg, Germany. Electronic address: .
Lindner C; Max Planck Institute of Psychiatry, Germany.
Leucht C; Max Planck Institute of Psychiatry, Germany.
Leucht S; Technical University of Munich, Germany.; Pokaż więcej
Źródło:: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Aug; Vol. 85, pp. 3-4. Date of Electronic Publication: 2024 Apr 20.
Typ publikacji:: Letter
MeSH Terms:: Clinical Trials as Topic*/methods
Clinical Trials as Topic*/standards
Humans ; Uncertainty ; Guidelines as Topic

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Bridging the gender gap in cardiovascular research: The role of cognitive biases in selection bias in clinical trials.
Autorzy:: La Rovere MT; Istituti Clinici Scientifici Maugeri IRCCS, Montescano (Pavia), Italy. Electronic address: .
Gorini A; Istituti Clinici Scientifici Maugeri IRCCS, Milano Camaldoli, Italy; Dipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, Italy.; Pokaż więcej
Źródło:: International journal of cardiology [Int J Cardiol] 2024 Oct 15; Vol. 413, pp. 132347. Date of Electronic Publication: 2024 Jul 11.
Typ publikacji:: Letter; Editorial
MeSH Terms:: Clinical Trials as Topic*/methods
Cardiovascular Diseases*/therapy
Humans ; Female ; Selection Bias ; Male ; Sexism ; Biomedical Research/methods ; Cognition/physiology

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: Optimizing assessments of quality of life in contemporary prostate cancer clinical trials.
Autorzy:: Morgans AK; Department of Medicine, Harvard Medical School and Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Cancer [Cancer] 2024 Oct 15; Vol. 130 (20), pp. 3406-3408. Date of Electronic Publication: 2024 Jul 27.
Typ publikacji:: Journal Article; Editorial
MeSH Terms:: Quality of Life*
Prostatic Neoplasms*/psychology
Prostatic Neoplasms*/therapy
Clinical Trials as Topic*/standards
Humans ; Male

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: Designing and optimizing clinical trials for long COVID.
Autorzy:: Vogel JM; Scripps Research Translational Institute, Scripps Research, La Jolla, CA, United States of America; Patient-Led Research Collaborative, United States of America. Electronic address: .
Pollack B; Patient-Led Research Collaborative, United States of America; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
Spier E; Patient-Led Research Collaborative, United States of America.
McCorkell L; Patient-Led Research Collaborative, United States of America.
Jaudon TW; Patient-Led Research Collaborative, United States of America; University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Fitzgerald M; Patient-Led Research Collaborative, United States of America.
Davis H; Patient-Led Research Collaborative, United States of America.
Cohen AK; Patient-Led Research Collaborative, United States of America; University of California San Francisco, Department of Epidemiology & Biostatistics and Philip R. Lee Institute for Health Policy Studies, 550 16th street, 2nd floor, San Francisco, CA 94158, United States of America.; Pokaż więcej
Źródło:: Life sciences [Life Sci] 2024 Oct 15; Vol. 355, pp. 122970. Date of Electronic Publication: 2024 Aug 13.
Typ publikacji:: Journal Article; Review
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/therapy
Clinical Trials as Topic*
Research Design*
SARS-CoV-2*
Humans ; Post-Acute COVID-19 Syndrome ; COVID-19 Drug Treatment ; Drug Repositioning/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of a digital intervention.
Autorzy:: An J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Ferrante JM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
Macenat M; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Ganesan S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Hudson SV; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
Omene C; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
Garcia H; Lawrence Herbert School of Communication, Hofstra University, Hempstead, New York, USA.
Kinney AY; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; School of Public Health, The State University of New Jersey, New Brunswick, New Jersey, USA.; Pokaż więcej
Źródło:: Cancer [Cancer] 2024 Oct 15; Vol. 130 Suppl 20, pp. 3561-3577. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasms*/therapy
Neoplasms*/psychology
Precision Medicine*/methods
Black or African American*
Clinical Trials as Topic*
Patient Participation*
Humans ; Pilot Projects ; Female ; Male ; Middle Aged ; Adult ; Aged ; Decision Making ; Health Knowledge, Attitudes, Practice ; Medical Oncology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 17.

Tytuł:: A critical systematic review of extracellular vesicle clinical trials.
Autorzy:: Mizenko RR; Department of Biomedical Engineering, University of California, Davis, California, USA.
Feaver M; Department of Biomedical Engineering, University of California, Davis, California, USA.
Bozkurt BT; Department of Biomedical Engineering, University of California, Davis, California, USA.
Lowe N; Department of Biomedical Engineering, University of California, Davis, California, USA.
Nguyen B; Department of Biomedical Engineering, University of California, Davis, California, USA.
Huang KW; Department of Biomedical Engineering, University of California, Davis, California, USA.
Wang A; Department of Biomedical Engineering, University of California, Davis, California, USA.; Department of Surgery, University of California, Davis, California, USA.
Carney RP; Department of Biomedical Engineering, University of California, Davis, California, USA.; Pokaż więcej
Źródło:: Journal of extracellular vesicles [J Extracell Vesicles] 2024 Oct; Vol. 13 (10), pp. e12510.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Extracellular Vesicles*/metabolism
Clinical Trials as Topic*
Humans ; Neoplasms/therapy ; Mesenchymal Stem Cells/metabolism ; Mesenchymal Stem Cells/cytology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Kidney function assessment for eligibility in clinical cancer trials - Data from the European Organisation for Research and Treatment of Cancer.
Autorzy:: Puhr HC; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. Electronic address: .
Xenophontos E; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Giraut A; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Litière S; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Boone L; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Bogaerts J; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Collienne M; European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium. Electronic address: .
Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. Electronic address: .; Pokaż więcej
Źródło:: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct; Vol. 210, pp. 114302. Date of Electronic Publication: 2024 Aug 31.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasms*
Clinical Trials as Topic*
Glomerular Filtration Rate*
Humans ; Male ; Female ; Aged ; Middle Aged ; Kidney Function Tests/methods ; Patient Selection ; Europe ; Eligibility Determination ; Kidney/physiopathology ; Creatinine/urine ; Creatinine/blood

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: Why have status epilepticus trials failed: Wrong drugs or wrong trials?
Autorzy:: Cock H; City St George's, University of London, School of Health and Medical Sciences, Neurosciences Clinical Academic Group, Cranmer Terrace, London SW17 0RE, UK. Electronic address: .; Pokaż więcej
Źródło:: Epilepsy & behavior : E&B [Epilepsy Behav] 2024 Oct; Vol. 159, pp. 110030. Date of Electronic Publication: 2024 Sep 01.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Status Epilepticus*/drug therapy
Anticonvulsants*/therapeutic use
Clinical Trials as Topic*
Humans ; COVID-19

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.
Autorzy:: Khaliq A; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS.
Wesson W; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS.
Logan E; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS.
Tabak C; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS.
Mushtaq MU; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS; US Myeloma Innovations Research Collaborative, Westwood, KS.
Lin T; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS.
Baranda J; Department of Medicine, University of Kansas Medical Center, Kansas City, KS.
Shune L; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Department of Medicine, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative, Westwood, KS.
Abdallah AO; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Department of Medicine, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative, Westwood, KS.
McGuirk J; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS.
Hamadani M; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Ahmed N; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS; Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Department of Medicine, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative, Westwood, KS. Electronic address: .; Pokaż więcej
Źródło:: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e344-e349. Date of Electronic Publication: 2024 May 31.
Typ publikacji:: Journal Article
MeSH Terms:: Authorship*
Lymphoma*/therapy
Antigens, CD19*/immunology
Antigens, CD19*/metabolism
Clinical Trials as Topic*
Multiple Myeloma*/therapy
Immunotherapy, Adoptive*/methods
Humans ; Female ; Male ; B-Cell Maturation Antigen

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Clinical Trials as Topic"" wg kryterium: Temat